drugset
drugset / Trial / NCT01323140

Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems

NCT01323140 ↗

Phase 2 Completed 40 enrolled Watson Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

Watson's testosterone transdermal system delivers male sex hormone through skin for the treatment of men with sex hormone insufficiency.

Timeline

Start
2011-04
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule — Other

Indications

hypogonadism